http://rdf.ncbi.nlm.nih.gov/pubchem/reference/36743807

Outgoing Links

Predicate Object
contentType Observational Study|Journal Article
issn 0920-1211
pageRange 107307-
startingPage 107307
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_6f6d8aa339ed72296a2e261f2a7299d7
bibliographicCitation Arai Y, Inaji M, Shimizu K, Kondo S, Hashimoto-Fujimoto S, Kiyokawa J, Kawano Y, Yamamoto S, Maehara T. Long-term efficacy and safety of perampanel as an add-on therapy in patients with epilepsy. Epilepsy Res. 2024 Feb;200():107307. doi: 10.1016/j.eplepsyres.2024.107307. PMID: 38286107.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cc14e893c8b3744967f237028d3ab6b2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f508cc8b0817d6cb29ac604473d31c40
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5263b67e348577e815ffc5d5579af8c4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_835c9fa76ed2350afb7baf7e359cf4c6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_279f5bb7766d17bc57064dffc81ac1e7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c645f4ad1975e46f76b39aa678695345
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5f69fabbe673b52fc499866c7815318b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0c0b9f36516384caed24c165e9607b05
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_eb13702494b5a08eb583c6d35ad4796c
date 202402
identifier https://doi.org/10.1016/j.eplepsyres.2024.107307
https://pubmed.ncbi.nlm.nih.gov/38286107
isPartOf https://portal.issn.org/resource/ISSN/0920-1211
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3587
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Long-term efficacy and safety of perampanel as an add-on therapy in patients with epilepsy
discusses http://id.nlm.nih.gov/mesh/M0028006
http://id.nlm.nih.gov/mesh/M0001382
http://id.nlm.nih.gov/mesh/M0018236
http://id.nlm.nih.gov/mesh/M0014878
http://id.nlm.nih.gov/mesh/M0000922
http://id.nlm.nih.gov/mesh/M0549034

Total number of triples: 30.